Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administration.
lipid-specific IgM bands in csf associated with a reduced risk of developing pml during treatment with natalizumab.
Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment Group.
Laquinimod suppress antigen presentation in relapsing-remitting multiple sclerosis: in-vitro high-throughput gene expression study.
Stress and the risk of multiple sclerosis.
Generation and Characterization of Fully Human Monoclonal Antibodies Against Human Orai1 for Autoimmune Disease.
Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis.
It is better to be in a clinical trial than not: lessons learnt from clinical neurology--the management of acute multiple sclerosis relapses.
Synthon announces successful outcome of the Phase III GATE study with its generic glatiramer acetate
Clinical and immunological follow-up of B-cell depleting therapy in CNS demyelinating diseases.
2nd Annual Congress on Neurology and Epidemiology
Cluster-tic syndrome as the initial manifestation of multiple sclerosis.
Acorda Therapeutics announces top line results of post-marketing commitment study exploring 5 mg dose of dalfampridine-ER
Early relapses, onset of progression, and late outcome in multiple sclerosis.
Ono to enter license agreements with Merck KGaA
[Plasmapheresis in central nervous system disorders].
Epstein-Barr virus in the multiple sclerosis brain: a controversial issue--report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria.
Exploratory analysis of predictors of patient adherence to subcutaneous interferon beta-1a in multiple sclerosis: TRACER study.
Increased axonal expression of nectin-1 in multiple sclerosis plaques.
The Many Facets of Cell Injury: Angiogenesis to Autophagy.
Assessment of sphingosine-1-phosphate receptor expression and associated intracellular signaling cascades in primary cells of the human central nervous system.
The epidemiology of multiple sclerosis in Latin America and the Caribbean: a systematic review.
2-Methoxyestradiol inhibits experimental autoimmune encephalomyelitis through suppression of immune cell activation.
Pelvic Floor Muscle Training With and Without Electrical Stimulation in the Treatment of Lower Urinary Tract Symptoms in Women With Multiple Sclerosis.
An Open Label Extension of the LAQ/5062 and LAQ/5063 Studies to Assess the Long Term Safety and Tolerability of Laquinimod 0.6mg in RRMS Patients

Pages